[1] White JJ, Ledbetter DH, Jr ER, et al. Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism. Genomics, 1991, 11: 228-230. [2] Peng YT, Chen P, Ouyang RY, et al. Multifaceted role of prohibitin in cell survival and apoptosis. Apoptosis, 2015, 20:1135-1149. [3] Signorile A, Sgaramella G, Bellomo F, et al. Prohibitins: a critical role in mitochondrial functions and implication in diseases. Cells, 2019, 8.pii: E71. [4] Dang SS, Sun MZ, Yang E, et al. Prohibitin is overexpressed in Huh-7-HCV and Huh-7.5-HCV cells harboring in vitro transcribed full-length hepatitis C virus RNA. Virol J, 2011, 8:424. [5] Ande SR, Nguyen KH, Grégoire Nyomba BL, et al. Prohibitin-induced,obesity-associated insulin resistance and accompanying low-grade inflammation causes NASH and HCC.Sci Rep, 2016, 6:23608. [6] Shi JJ, Yang Y, Wu FP, et al. Prohibitin 1 induced apoptosis in human hepatocellular carcinoma cells via the p53-mediated mitochondrial pathway. Hepatology, 2018, 68(Sup 1):1280A-1281A. [7] 石娟娟, 杨宁, 吴凤萍,等.肝癌患者血清和组织中prohibitin的表达及其临床意义. 肝脏, 2016 , 21:920-923. [8] Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers, 2016, 2:16018-16040. [9] Shi JJ, Jia XL, Li M, et al. Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.World J Gastroenterol, 2015, 21:13277-13287. [10] Ko KS, Tomasi ML, Iglesias-Ara A, et al. Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice. Hepatology, 2010, 52:2096-2108. [11] Xu ZB, Wu JH, Zha XL. Up-regulation of prohibitin 1 is involved in the proliferation and migration of liver cancer cells. Sci China Life Sci, 2011, 54:121-127. [12] Mavila N, Tang Y, Berlind J, et al. Prohibitin 1 acts as a negative regulator of Wingless/Integrated-Beta-Catenin signaling in murine liver and human liver cancer cells. Hepatol Commun, 2018, 2:1583-1600. [13] Peng X, Mehta R, Wang S, et al. Prohibitin is a novel target gene of vitamin D involved in its antiproliferative action in breast cancer cells. Cancer Res, 2006, 66:7361-7369. [14] Wang X, Simpson E R, Brown K A. p53: protection against tumor growth beyond effects on cell cycle and apoptosis. Cancer Research, 2015, 75:5001-5007. [15] Harper JW, Adami GR, Wei N, et al. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 1993, 75:805-816. [16] Polier G, Neumann J, Thuaud F, et al. The natural anticancer compounds rocaglamides inhibit the Raf-MEK-ERK pathway by targeting prohibitin 1 and 2. Chem Biol, 2012, 19:1093-1104. |